These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28693610)

  • 1. GATA3 is a sensitive marker for primary genital extramammary paget disease: an immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15.
    Zhao M; Zhou L; Sun L; Song Y; Guo Y; Zhang X; Zhao F; Wang P; Yue J; Niu D; Li Z; Huang X; Kang Q; Jia L; Lai J; Cao D
    Diagn Pathol; 2017 Jul; 12(1):51. PubMed ID: 28693610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
    Yang Y; Lu S; Zeng W; Xie S; Xiao S
    Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors.
    Sangoi AR; Shrestha B; Yang G; Mego O; Beck AH
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):229-37. PubMed ID: 25906123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 expression in primary vulvar Paget disease: a potential pitfall leading to misdiagnosis of pagetoid urothelial intraepithelial neoplasia.
    Morbeck D; Tregnago AC; Baiocchi G; Sacomani C; Peresi PM; Osório CT; Schutz L; Bezerra SM; de Brot L; Cunha IW
    Histopathology; 2017 Feb; 70(3):435-441. PubMed ID: 27633145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
    Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
    J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Extramammary Paget Disease of the Vulva With Signet Ring Cell Morphology in a Patient With Signet Ring Cell Carcinoma of the Stomach: Report of a Case.
    Jeong BK; Kim KR
    Int J Gynecol Pathol; 2018 Mar; 37(2):147-151. PubMed ID: 28582341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perianal Paget's disease: a histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma.
    Goldblum JR; Hart WR
    Am J Surg Pathol; 1998 Feb; 22(2):170-9. PubMed ID: 9500217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulvar Paget's disease: a clinicopathologic and immunohistochemical study of 19 cases.
    Goldblum JR; Hart WR
    Am J Surg Pathol; 1997 Oct; 21(10):1178-87. PubMed ID: 9331290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
    Wendroth SM; Mentrikoski MJ; Wick MR
    Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer.
    Krings G; Nystrom M; Mehdi I; Vohra P; Chen YY
    Hum Pathol; 2014 Nov; 45(11):2225-32. PubMed ID: 25150746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinicopathological study of perianal Paget's disease associated with internal rectal adenocarcinoma].
    Liu CF; Wang Q; Kong YY; Tu XY; Wang J; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):11-5. PubMed ID: 14989921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
    Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The prognosis and immunohistochemical evaluation of five perianal Paget's disease cases].
    Amano K; Kumamoto K; Ohsawa T; Okada N; Ishibashi K; Inokuma S; Nakada H; Yokoyama M; Haga N; Ishida H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2653-5. PubMed ID: 21224669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extramammary Paget Disease-A Challenging Case.
    Yildiz P; Ronen S; Aung PP; Trinidad C; Kajoian A; Prieto VG
    Am J Dermatopathol; 2019 Nov; 41(11):867-868. PubMed ID: 30807292
    [No Abstract]   [Full Text] [Related]  

  • 20. Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancer.
    Jamidi SK; Hu J; Aphivatanasiri C; Tsang JY; Poon IK; Li JJ; Chan SK; Cheung SY; Tse GM
    Histopathology; 2020 Dec; 77(6):936-948. PubMed ID: 32304249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.